Financials data is unavailable for this security.
View more
Year on year Mesa Laboratories Inc had net income fall from a gain of 930.00k to a loss of 254.25m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 40.10% to 41.72%.
| Gross margin | 62.47% |
|---|---|
| Net profit margin | -107.56% |
| Operating margin | -113.44% |
| Return on assets | -45.02% |
|---|---|
| Return on equity | -89.46% |
| Return on investment | -54.70% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Mesa Laboratories Inc fell by 4.70m. However, the company earned 44.13m from its operations for a Cash Flow Margin of 20.41%. In addition the company generated 32.84m cash from financing while 81.31m was spent on investing.
| Cash flow per share | -40.36 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 29.79 |
|---|---|
| Tangible book value per share | -24.19 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.7047 |
|---|---|
| Quick ratio | 0.5106 |
| Total debt/total equity | 1.27 |
|---|---|
| Total debt/total capital | 0.5594 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -27,310.62%. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.32% |
|---|---|
| Div growth rate (5 year) | 0.00% |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -34,200.46 |
More ▼
